Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Knightscope, Inc. stock logo
KSCP
Knightscope
$3.00
$3.51
$2.52
$10.14
$50.75M1.26442,502 shs627,880 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$29.00
$25.40
$19.35
$66.85
$1.65B0.831.72 million shs1.12 million shs
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$1.92
$1.89
$1.70
$3.59
$187.66M1.34351,587 shs408,885 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Knightscope, Inc. stock logo
KSCP
Knightscope
0.00%+1.69%-4.46%-20.00%-48.45%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.00%+11.03%+19.05%+5.99%-49.46%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
0.00%+3.78%-0.52%-10.28%-7.25%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Knightscope, Inc. stock logo
KSCP
Knightscope
$3.00
$3.51
$2.52
$10.14
$50.75M1.26442,502 shs627,880 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$29.00
$25.40
$19.35
$66.85
$1.65B0.831.72 million shs1.12 million shs
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$1.92
$1.89
$1.70
$3.59
$187.66M1.34351,587 shs408,885 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Knightscope, Inc. stock logo
KSCP
Knightscope
0.00%+1.69%-4.46%-20.00%-48.45%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.00%+11.03%+19.05%+5.99%-49.46%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
0.00%+3.78%-0.52%-10.28%-7.25%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Knightscope, Inc. stock logo
KSCP
Knightscope
2.50
Moderate Buy$15.33411.11% Upside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.43
Hold$41.4542.95% Upside
Stereotaxis Inc. stock logo
STXS
Stereotaxis
3.00
Buy$3.88101.82% Upside

Current Analyst Ratings Breakdown

Latest STXS, KSCP, and PRCT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2026
Stereotaxis Inc. stock logo
STXS
Stereotaxis
Reiterated RatingOverweight$4.00 ➝ $3.50
4/30/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Reiterated RatingOverweight$28.00 ➝ $35.00
4/21/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Reiterated RatingSell (E+)
4/15/2026
Knightscope, Inc. stock logo
KSCP
Knightscope
Boost Price TargetBuy$25.00 ➝ $26.00
3/31/2026
Knightscope, Inc. stock logo
KSCP
Knightscope
Reiterated RatingBuy$12.00
3/6/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Initiated CoverageNeutral$30.00
3/5/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
UpgradeHold
2/27/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Lower Price TargetBuy$47.00 ➝ $30.00
2/26/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Lower Price TargetOverweight$51.00 ➝ $34.00
2/26/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
DowngradeStrong-BuyHold
2/26/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Lower Price TargetOutperform$55.00 ➝ $30.00
(Data available from 5/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Knightscope, Inc. stock logo
KSCP
Knightscope
$14.43M3.52N/AN/A$2.01 per share1.49
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$322.02M5.13N/AN/A$6.11 per share4.75
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$32.38M5.80N/AN/A$0.15 per share12.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Knightscope, Inc. stock logo
KSCP
Knightscope
-$33.81M-$3.54N/AN/AN/A-257.99%-143.53%-87.05%8/11/2026 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$95.57M-$1.82N/AN/AN/A-31.82%-27.70%-20.29%8/5/2026 (Estimated)
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-$21.64M-$0.28N/AN/AN/A-69.50%-163.30%-30.08%8/6/2026 (Estimated)

Latest STXS, KSCP, and PRCT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
Knightscope, Inc. stock logo
KSCP
Knightscope
-$0.52-$0.74-$0.22-$0.74$3.65 million$6.02 million
4/29/2026Q1 2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.55-$0.56-$0.01-$0.56$80.52 million$83.13 million
3/27/2026Q4 2025
Knightscope, Inc. stock logo
KSCP
Knightscope
-$0.73-$0.92-$0.19-$0.92$2.50 million$2.54 million
3/9/2026Q4 2025
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-$0.06-$0.06N/A-$0.06$9.24 million$8.64 million
2/25/2026Q4 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.32-$0.53-$0.21-$0.53$93.70 million$76.38 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Knightscope, Inc. stock logo
KSCP
Knightscope
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Knightscope, Inc. stock logo
KSCP
Knightscope
0.12
1.51
3.64
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.15
6.73
5.51
Stereotaxis Inc. stock logo
STXS
Stereotaxis
N/A
1.56
1.11

Institutional Ownership

CompanyInstitutional Ownership
Knightscope, Inc. stock logo
KSCP
Knightscope
14.61%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
45.35%

Insider Ownership

CompanyInsider Ownership
Knightscope, Inc. stock logo
KSCP
Knightscope
3.83%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
6.60%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
16.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
Knightscope, Inc. stock logo
KSCP
Knightscope
4016.92 million16.27 millionNot Optionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43056.92 million53.16 millionOptionable
Stereotaxis Inc. stock logo
STXS
Stereotaxis
13097.74 million82.07 millionNot Optionable

Recent News About These Companies

Stereotaxis Q1 Earnings Call Highlights
Roth MKM Reaffirms Their Buy Rating on Stereotaxis (STXS)
Stereotaxis to acquire Robocath for up to $45M
Stereotaxis to acquire Robocath for $20M upfront
Stereotaxis, Inc. (STXS) M&A Call Transcript
Stereotaxis Earnings Call: Growth Promise Amid Strains

New MarketBeat Followers Over Time

Media Sentiment Over Time

Knightscope stock logo

Knightscope NASDAQ:KSCP

$3.00 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$3.01 +0.01 (+0.33%)
As of 05/22/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Knightscope, Inc. designs, develops, manufactures, markets, deploys, and supports autonomous security robots (ASR) in the United States. Its products include K3 and K5 ASRs designed to roam a geo-fenced area autonomously by utilizing numerous sensors and lasers, either on a random basis or based on a particular patrolling algorithm to navigate around people, vehicles, and objects in dynamic indoor or outdoor environments; K1, an ASR for used in indoors or outdoors and at ingress/egress points for both people and vehicles; and K7, a multi-terrain ASR. The company also develops and operates the Knightscope security operations center (KSOC), a browser-based interface, which allows real-time data access service to its clients for alert of an abnormal event; and Knightscope network operations center (KNOC), a custom set of tools that enables it to manage and monitor the network of ASRs with alerts related to critical indicators and statistics, including charging, software, navigation, and temperatures, as well as to execute over-the-air software upgrades, patches, and other related items. In addition, it offers Knightscope+, a virtual monitoring and response solution that provides an alternative for client sites. The company serves airports, commercial real estate, corporate campus, homeowner associations, hotels, universities, municipalities, rail, healthcare, public parks, schools, casinos, corporations, logistics, manufacturing, law enforcement, Parking areas, municipalities, universities, and property management companies, as well as the U.S. federal government. Knightscope, Inc. was incorporated in 2013 and is headquartered in Mountain View, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$29.00 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$28.93 -0.07 (-0.23%)
As of 05/22/2026 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Stereotaxis stock logo

Stereotaxis NYSEAMERICAN:STXS

$1.92 0.00 (0.00%)
Closing price 05/22/2026 04:10 PM Eastern
Extended Trading
$1.92 0.00 (0.00%)
As of 05/22/2026 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.